Pfizer files second lawsuit against Metsera, Novo Nordisk

Core Viewpoint - Pfizer Inc has filed a second lawsuit against its controlling shareholder Metsera and Novo Nordisk, alleging anticompetitive behavior by the Danish pharmaceutical company [1] Group 1 - The lawsuit was filed in a federal court in Delaware [1] - Pfizer claims that Novo Nordisk's actions are detrimental to competition in the pharmaceutical market [1] - This legal action marks a continuation of Pfizer's efforts to address perceived anticompetitive practices [1]